Lv4
548 积分 2022-06-14 加入
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial
2天前
已完结
Heterogeneous responses of IM19 anti-CD19 CAR T-cell therapy in refractory systemic lupus erythematosus: an open-label pilot study and a mini-review
15天前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
27天前
已完结
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
1个月前
已完结
A branched ionizable lipid nanoparticle platform for versatile in vivo delivery of nucleic acids: Validation from mRNA to capped circular RNA
1个月前
已完结
Safety and efficacy of low-dose, cord blood-derived CD19 CAR-NK cells with 4-1BB co-stimulation in refractory systemic lupus erythematosus
2个月前
已完结
Immune Effector Cell-Associated HLH-Like Syndrome (IEC-HS) in CAR-T and TCE-Treated Myeloma and B-Cell Malignancies: Insights from a Pharmacovigilance Study
2个月前
已完结
CD19 CAR-T therapy induces remission in refractory autoimmune hemolytic anemia with ITP and antiphospholipid syndrome
2个月前
已完结
Resetting autoimmune disease with CAR cell therapies
2个月前
已完结
Pre-intervention with intravenous immunoglobulin reverses the immunogenic clearance of PEGylated nanomedicines
2个月前
已完结
皖公网安备34019202002308
